Our research into identifying new target genes for lung cancer therapy within the framework of external stimuli has brought to light two prominent candidates: AURKA downregulation and Cadherin 1 (CDH1) upregulation, also known as E-cadherin (Fig. 6). This evidence concerns the gene AURKA and lung carcinoma.